John Beckes
Hospitalist · National City, CANPI 1639118912
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,395 of the $3,761 with a category attached, or 63.7%. Modernatx, Inc. accounts for 81.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $3,065 and has fallen 81.4% since, to $571 in 2024. Among hospitalist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $188.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$3K
- Merck$571
- Biosense Webster, Inc.$125
- Novartis$19
Across 10,538 payments — averaging $1470.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$9.4M
- Regeneron$1.4M
- Braintree Laboratories, Inc.$778K
- Lexicon Pharmaceuticals, Inc.$769K
- Merck$576K
- Amgen$510K
- plus $2M from 14 others
What the payments were for
- Travel & lodging$2,39564%
- Food & beverage$1,36636%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 8 | $3,046 |
| Merck | 10 | $571 |
| Biosense Webster, Inc. | 1 | $125 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$125
How this compares
$3,761 in reported general payments places this provider in the 95th percentile of 2,469 hospitalist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 17 | $12,215 |
| Olanzapine | 14 | $1,522 |
| Ranolazine ErRanolazine | 20 | $1,365 |
| Levothyroxine Sodium | 94 | $1,048 |
| Quetiapine Fumarate | 45 | $937 |
| Tamsulosin Hcl | 27 | $830 |
| Potassium Chloride | 27 | $740 |
| Atorvastatin Calcium | 46 | $553 |
| Trazodone Hcl | 47 | $483 |
| Rosuvastatin Calcium | 20 | $457 |
| Pantoprazole Sodium | 23 | $450 |
| Latanoprost | 13 | $378 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $372 |
| Memantine Hcl | 16 | $372 |
| Metformin Hcl ErMetformin Hcl | 14 | $352 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in National City
- Jennifer SchneiderSanta Rosa$1.2M
- Soham ShahBakersfield$844K
- Alpesh AminOrange$428K
- Retha GoodglickSanta Monica$156K
- Robert WachterSan Francisco$75K
- Steven WongTorrance$36K
- Edward LeeLos Angeles$30K
- Anjani KolahiOrange$30K
- Omar AldaasSan Diego$24K
- Summaiya MuhammadCastro Valley$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.